Lim Bryant David
SEC insider (Form 3/4/5 filer). CIK 0001752888. CLO, CFO, Corp Sec. at Prelude Therapeutics Inc (PRLD). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 4, 2026. Located in WILMINGTON, DE.
Companies Lim Bryant David has filed insider reports for
- Prelude Therapeutics Inc (PRLD): Officer, CLO, CFO, Corp Sec.
Lim Bryant David
CIK: 0001752888
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PRLD
Prelude Therapeutics Inc
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 4, 2026PRLD
Prelude Therapeutics Inc
AwardDirectEmployee Stock Option (right to buy)
275K shares- - Feb 4, 2025PRLD
Prelude Therapeutics Inc
AwardDirectEmployee Stock Option (right to buy)
200K shares- - Dec 19, 2024PRLD
Prelude Therapeutics Inc
PurchaseDirect25K shares at avg. $0.91$23K
1-3 of 3 transactions